ORIC - Oric Pharmaceuticals Inc
Oric Pharmaceuticals Inc Logo

ORIC - Oric Pharmaceuticals Inc

https://www.oricpharma.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. The company is headquartered in South San Francisco, California.

52W High
$14.67
52W Low
$3.90
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.63
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
0.13
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
3.26
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
6.94%
Institutions (25–75% balanced)
99.19%
Shares Outstanding
97,123,000
Float
63,297,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-1.89
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.44%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.2537
Previous
0.2476
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025